Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Volume Reduction and Process Optimization with Cadence Inline Concentrator
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Headline News
Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer
Jemperli achieves 76% complete response rate in Phase II rectal cancer trial
FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Overcoming Antibody-Drug Conjugate (ADC) Process Development & Manufacturing Challenges
Presented by Dr. Jimmy Li, CEO of WuXi XDC (a WuXi Biologics subsidiary)
23rd February 2022
Material Understanding for Continuous Manufacturing of Solid Dosage Forms
Presented by Dr Yifan Wang, Regulatory Research Scientist, FDA CDER and Dirk Leister, Leader Technical Marketing Thermo Fisher Scientific
23rd August 2018
Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review
Presented by John Duguid, Executive Director, Research & Development at Vericel Corporation and Lori Daane, Pharma Microbiology Sr. Scientific Director at bioMérieux and Mike Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
01st November 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Lifetime study for JSR Amsphere A3 – protein A resin
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
